Oblenio Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$62M
- Investors
-
5
Oblenio Bio General Information
Description
Operator of a biotechnology company intended to transform the treatment of severe autoimmune diseases. The company is focused on realizing the significant potential of T-cell engagers as a novel therapeutic approach that addresses underlying disease pathophysiology and enables immune reset, enabling clients to target these therapies across various diseases.
Contact Information
Website
www.obleniobio.comCorporate Office
- 4 Maguire Road
- Lexington, MA 02421
- United States
Corporate Office
- 4 Maguire Road
- Lexington, MA 02421
- United States
Oblenio Bio Timeline
Oblenio Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 25-Jun-2026 | $62M | Completed | Clinical Trials - General | ||
| 2. Early Stage VC (Series A) | Completed | Pre-Clinical Trials | ||||
| 1. Joint Venture | 07-Nov-2024 | Completed | Pre-Clinical Trials |
Oblenio Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A-2 | 1,269,705 | $0.000100 | 2% | $4.21 | $4.21 | 1x | $4.21 | 6.21% |
| Series A-1 | 7,000,000 | $0.000100 | 2% | $4.21 | $4.21 | 1x | $4.21 | 34.25% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Oblenio Bio Signals
Oblenio Bio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Deep Track Capital | Venture Capital | Minority | ||
| GV | Corporate Venture Capital | Minority | ||
| Pfizer Ventures | Corporate Venture Capital | Minority | ||
| Aditum Bio | Venture Capital | Majority | ||
| Leads Biolabs | Corporation | Majority |
Oblenio Bio FAQs
-
When was Oblenio Bio founded?
Oblenio Bio was founded in 2024.
-
Where is Oblenio Bio headquartered?
Oblenio Bio is headquartered in Lexington, MA.
-
What is the size of Oblenio Bio?
Oblenio Bio has 6 total employees.
-
What industry is Oblenio Bio in?
Oblenio Bio’s primary industry is Biotechnology.
-
Is Oblenio Bio a private or public company?
Oblenio Bio is a Private company.
-
What is the current valuation of Oblenio Bio?
The current valuation of Oblenio Bio is .
-
What is Oblenio Bio’s current revenue?
The current revenue for Oblenio Bio is .
-
How much funding has Oblenio Bio raised over time?
Oblenio Bio has raised $96.5M.
-
Who are Oblenio Bio’s investors?
Deep Track Capital, GV, Pfizer Ventures, Aditum Bio, and Leads Biolabs have invested in Oblenio Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process